The "Fast Money" traders give their top picks for all-American stocks. » Read More
U.S. stock futures were higher this morning. U.S. oil prices were basically flat.
Markets are already tilting toward Friday's jobs report, but data on the services sector Thursday could prove important.
Supermarket giant Kroger reports earnings Thursday and could give a glimpse into how its recent deals are doing, and what to expect going forward.
Key will be upcoming economic news, particularly Friday's jobs report, which is the last big piece of data ahead of the Fed's March meeting.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including a cautious report out on Palo Alto Networks.
The largest supermarket chain in the US is in the second round of bidding for the grocery retailer.
CNBC's Dom Chu explains the details behind Kroger's bid to acquire Fresh Market according to reports from Reuters.
Whole Foods shares climbed after earnings, and some "Fast Money" traders believe the grocer's stock could continue to rise.
The "Fast Money" traders give you 3 trades in supermarkets on Whole Foods earnings.
CNBC's Jane Wells covers the results of Whole Foods' latest quarter.
Jim Cramer rattles off his take on caller favorite stocks, including this play on food that many investors thought was safe to hide behind.
Jim Cramer prepares investors with his shopping list of stocks to avoid and buy amid the worldwide sell-off.
Jim Cramer declared 2015 as the year of the haves and have-not stocks. He has these conclusions for your portfolio.
As a mixed year for retail stocks comes to a close, "Fast Money" traders picked their best consumer bets for 2016.
Some of the names on the move ahead of the open.
Jim Cramer reveals his secret way to get ahead on Wall Street and prepare for opportunities.
The sharp drop in crude oil prices Friday could be positive for a certain group of stocks, if history is any guide.
Jim Cramer provides his opinion on caller favorite stocks, including this telecommunications play.
Michael Khouw, president and chief strategist at Optimize Advisors, shares an options strategy for the days ahead.
AquaBounty has received approval from the FDA to sell its AquAdvantage salmon in the US, but critics have denounced the 'frankenfish.'